Inovio stock plunges more than 34% as FDA puts Covid-19 vaccine trial on hold

The FDA wants the Plymouth Meeting company to answers some questions before it can move forward with late-stage testing of the experimental vaccine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.